simulated IL-6-stimulated ovarian cancer cell proliferation, migration, and apoptosis, as well as STAT3 pathway activation processes, based on a multi-scale ovarian cancer model, and the simulation results were consistent with recent experimental evidence that STAT3 ovarian cancer cells have high levels of survival and drug resistance (47). The gene discussed is STAT3; the disease is ovarian cancer.